154 related articles for article (PubMed ID: 20385985)
1. Prolonged relapse-free survival in two patients with an isolated brain metastasis from epithelial ovarian carcinoma.
Choo BA; Walji N; Spooner D; Barber P; Fernando IN
J Clin Oncol; 2010 Jun; 28(17):e271-2. PubMed ID: 20385985
[No Abstract] [Full Text] [Related]
2. Brain metastasis of ovarian epithelial carcinoma.
Sun HD; Chao KC; Shen SH; Lai CR; Twu NF; Yuan CC; Yen MS; Wu HH; Chen YJ
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):101-4. PubMed ID: 20466304
[No Abstract] [Full Text] [Related]
3. [Cerebral metastases in patients with epithelial ovarian carcinoma].
Zhao Y; Qian H; Li W
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):420-2. PubMed ID: 11360655
[TBL] [Abstract][Full Text] [Related]
4. [Unique cerebral metastasis of ovarian origin].
Lortholary A; Jadaud E; Hayek G; Bagory G; Bertrand AF; Fondrinier E
Presse Med; 1998 Jun; 27(20):966-7. PubMed ID: 9767841
[No Abstract] [Full Text] [Related]
5. Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma.
Choi CH; Kim TJ; Kim WY; Ahn GH; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2007 Jun; 105(3):762-8. PubMed ID: 17383715
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
[TBL] [Abstract][Full Text] [Related]
7. Hybrid endometrial carcinoma with short non-villous papillae and serous papillary carcinoma.
Box A; Raj G; Otton G; Bonaventura A; Scurry J
Pathology; 2010 Jan; 42(1):97-9. PubMed ID: 20025494
[No Abstract] [Full Text] [Related]
8. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
Liu JF; Hirsch MS; Lee H; Matulonis UA
Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
[TBL] [Abstract][Full Text] [Related]
10. Cervical metastasis as the first manifestation of ovarian papillary serous carcinoma.
Maki C; Groen J; Delgado B; Piura B
J Obstet Gynaecol; 2010 Apr; 30(3):325-6. PubMed ID: 20373951
[No Abstract] [Full Text] [Related]
11. [Analysis of long-term prognostic factors of epithelial ovarian cancer].
Li MD; Li YJ; Huang YW; Huang H
Ai Zheng; 2004 Nov; 23(11):1306-10. PubMed ID: 15522179
[TBL] [Abstract][Full Text] [Related]
12. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome.
Cohen ZR; Suki D; Weinberg JS; Marmor E; Lang FF; Gershenson DM; Sawaya R
J Neurooncol; 2004 Feb; 66(3):313-25. PubMed ID: 15015663
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer.
Hernando JJ; Park TW; Fischer HP; Zivanovic O; Braun M; Pölcher M; Grünn U; Leutner C; Pötzsch B; Kuhn W
Lancet Oncol; 2007 May; 8(5):451-4. PubMed ID: 17466904
[No Abstract] [Full Text] [Related]
14. [Clinical case of the month. Ovarian cancer metastasis to the pectoral muscle].
Benoit A; Jerusalem G; Gennigens C
Rev Med Liege; 2013 Nov; 68(11):557-61. PubMed ID: 24396968
[TBL] [Abstract][Full Text] [Related]
15. Intradural extramedullary spinal metastasis from an ovarian carcinoma.
Mehrotra R; Sharma K
Indian J Cancer; 2002; 39(4):157-60. PubMed ID: 12928577
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of radiotherapy for state I ovarian carcinoma].
Sheng X; Sun J; Zhou C
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
[TBL] [Abstract][Full Text] [Related]
17. Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum.
Hinson SA; Silva EG; Pinto K
Ann Diagn Pathol; 2013 Jun; 17(3):302-4. PubMed ID: 22921726
[TBL] [Abstract][Full Text] [Related]
18. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
19. [Metastatic brain tumor after chemotherapy of ovarian cancer].
Fukuda K; Chen JT; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K; Sakamoto A
Gan No Rinsho; 1987 Jan; 33(1):115-8. PubMed ID: 3102810
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of the dissemination process in patients with serous cystadenocarcinoma of the ovaries].
Dzhilavian GA
Vopr Onkol; 1984; 30(8):83-6. PubMed ID: 6485289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
